{'fraction_non_alphanumeric': 0.0384967919340055, 'fraction_numerical': 0.012832263978001834, 'mean_word_length': 5.423529411764706, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Increased serum levels of alpha-2-macroglobulin in severe chronic airflow obstruction.

Serum levels of alpha-2-macroglobulin, the major proteinase inhibitor besides alpha-1-antitrypsin, were investigated in 20 patients with severe Chronic Airflow Obstruction (CAO), as compared to 20 age- and sex-matched controls. Alpha-2-macroglobulin was assessed by rocket immuno-electrophoresis, and alpha-1-antitrypsin by a laser-nephelometric method. All patients had spirometric values determined, including diffusing capacity. The reversibility test for isoprenalin was performed. Alpha-2-macroglobulin levels were found to be significantly elevated in patients with CAO, even when two patients with alpha-1-antitrypsin deficiency were omitted from the statistical evaluation. Except for these two patients, there was no difference in alpha-1-antitrypsin level between the patients and the control group. It is concluded that elevated levels of alpha-2-macroglobulin are associated with the development of severe CAO and emphysematous lesions, also in the absence of alpha-1-antitrypsin deficiency.